Skip to main content
OrthoVellumOrthopaedic Exam Prep
Pricing
About OrthoVellum
OrthoVellum
A living orthopaedic atlas

Exam-focused orthopaedic references, a question bank, viva practice, and spaced-repetition revision — with every clinical claim traceable to its source. Content is educational only and is not a substitute for local supervision, clinical judgement, or institutional policy.

Library

  • Clinical Topics
  • Blog
  • Site Updates
  • Content Methodology

Company

  • About Us
  • Authors & Disclosure
  • Editorial Team
  • Editorial Policy
  • Advertising Policy

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA

Support

  • Support OrthoVellum
  • Help Center
  • Contact
  • Accessibility
Evidence. Clarity. Practice.

© 2026 OrthoVellum. For educational purposes only.

Not medical advice. Verify clinically important information against current local guidance.

Back to Research
Level IMust KnowTraumaConsensus Guideline

Evidence brief

CHEST VTE Guidelines

Prevention of VTE in Orthopedic Surgery Patients: CHEST Guideline and Expert Panel Report

Authors
Falck-Ytter Y, Francis CW, Johanson NA, et al
Journal
Chest
Year
2012

Key Findings

  • 1

    Recommends pharmacological prophylaxis for major orthopaedic surgery

  • 2

    LMWH, fondaparinux, low-dose UFH, aspirin, vitamin K antagonists, or rivaroxaban acceptable

  • 3

    Minimum 10-14 days prophylaxis, extended to 35 days for hip/knee arthroplasty

  • 4

    Mechanical prophylaxis alone acceptable when bleeding risk high

  • 5

    Timing of first dose balanced against bleeding risk

Clinical Implications

CHEST guidelines provide framework for VTE prevention in orthopaedic surgery. They support pharmacological prophylaxis as default but allow flexibility based on bleeding risk and patient factors.

Teaching Note

Know CHEST recommendations: LMWH most commonly used in Australia (enoxaparin 40mg daily or 0.5mg/kg BD). Duration: minimum 10-14 days, extend to 35 days for THA/TKA. Aspirin emerging as acceptable alternative. Discuss balancing bleeding vs thrombosis risk.

Citation

Falck-Ytter Y et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Guidelines. Chest. 2012;141(2 Suppl):e419S-e496S.

PubMedDOI

Evidence Level

I

Level I

Systematic review of RCTs or high-quality RCT

Topics

VTE prophylaxisDVTPEguidelinesthromboprophylaxis

Related Topics

  • Venous Thromboembolism
  • Hip Arthroplasty
  • Perioperative Management

External Links

View on PubMedView via DOI

Related Papers

I

EAST Open Fracture Guidelines

Hoff WS (2011)

V

ATLS Protocol

American College of Surgeons Committee on Trauma (2018)

I

FLOW Trial

FLOW Investigators (2015)

I

SPRINT Trial

Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures Investigators (2008)